UNIVEC Heralds Work of Scientists Pointing to Unsterile Injections as Source of Worldwide AIDS and Hepatitis Cases

[Guest guest]

UNIVEC Heralds Work of Scientists Pointing to Unsterile

Injections as Source of Worldwide AIDS and Hepatitis Cases

Wednesday September 13 9:20am

Source: BusinessWire

FARMINGDALE, N.Y.--(BUSINESS WIRE)--Sept. 13, 2000--

Researchers Recommend Curtailing Massive Unsterile Injecting

Warn of Possible Disease Mutations as a Result of Unsafe Practices

The Farmingdale-based UNIVEC Corporation (Nasdaq:UNVC), the

internationally recognized maker of auto-disable syringes, is heralding

Preston Marx, Ph.D. and Ernest Drucker, Ph.D. on the release of their paper,

" The Injection Century: Consequences of Massive Unsterile Injecting for the

Emergence of Human Pathogens " at the Royal Society in London at a meeting

entitled " Origins of HIV and the AIDS Epidemic. "

In the paper, these world-renowned scientists substantiate

UNIVEC's long held claim that " continued massive unsterile injecting has the

capacity to significantly alter the global ecology of infectious diseases,

accelerating epidemic spread of human pathogens. " According to Dr. Marx,

Tulane University's Director of AIDS Research and Chief of Virology, and Dr.

Drucker, Director of the Division of Community Health at New York City's

Montefiore Medical Center, the introduction of antibiotics in the 1950's led

to an abrupt and massive increase in unsterile injections and transmission

of several newly emerged human pathogens, significantly HIV and Hepatitis B

and C. The doctors warn that new strains of HIV or other pathogens could

emerge as a result of current practices.

" In addition to facilitating the spread of existing diseases, "

say Drs. Marx and Drucker, " massive unsterile injecting may also have

fostered the creation of new ones. "

" We hypothesize that the massive increase in unsterile injecting

in Africa associated with the introduction of antibiotics in the 1950's was

the modern `event' that allowed several weakly pathogenic simian virus, long

native to Sub Saharan Africa, to increase in pathogenicity and complete

their genetic adaptation to human hosts, emerging as the first epidemic

strain of HIV by 1959. "

Schoenfeld, Chairman of UNIVEC, said, " these respected

experts confirm our call for the exclusive use of auto-disable syringes in

mass immunization programs and for clinical use. As the World Health

Organization estimates, unsafe injections cause approximately 30,000 new HIV

infections, 8 million HBV infections and 1.2 million HCV infections

world-wide every year. "

" Why does the world's medical community continue to ignore these

figures?, " said Schoenfeld. " What it should do is stop the practice of

allowing multi-use syringes in every immunization and clinical program the

world over. Only when we adopt an auto-disable syringe policy, to be

mandatory in all mass vaccination programs, will we contribute significantly

to the scourge of disease around the world. "

The UNIVEC technology is for auto-disable syringes that can

effectively deliver vaccines in a safer manner than with traditional

syringes. The UNIVEC syringe prevents re-use and the needless spread of

disease. The devices can deliver predetermined doses from 0.05 to 1cc needed

to deliver medication, including vaccines, which may prevent contagious

diseases from spreading.

UNIVEC is a world leader in auto-disable syringes and is leading

the global movement for a conversion to auto-disable syringes from

traditional multi-use syringes. Traditional multi-use disposable syringes

are acknowledged by the World Health Organization to be responsible for the

spread of disease to millions of people each year.

Statements herein that are not descriptions of historical facts

are forward-looking and subject to risk and uncertainties. Actual results

could differ materially from those currently anticipated due to a number of

factors, including those set forth in the company's Securities and Exchange

filings under " Risk Factors, " including risks relating to dependence on

third parties; future capital needs; and risks relating to the

commercialization, if any, of the company's proposed products (such as

marketing, safety, regulatory, patent product liability, supply, competition

and other risks.)

Contact: UNIVEC Corporation

Schoenfeld, 631/777-2000

UNIVEC@...

[Guest guest]

UNIVEC Heralds Work of Scientists Pointing to Unsterile

Injections as Source of Worldwide AIDS and Hepatitis Cases

Wednesday September 13 9:20am

Source: BusinessWire

FARMINGDALE, N.Y.--(BUSINESS WIRE)--Sept. 13, 2000--

Researchers Recommend Curtailing Massive Unsterile Injecting

Warn of Possible Disease Mutations as a Result of Unsafe Practices

The Farmingdale-based UNIVEC Corporation (Nasdaq:UNVC), the

internationally recognized maker of auto-disable syringes, is heralding

Preston Marx, Ph.D. and Ernest Drucker, Ph.D. on the release of their paper,

" The Injection Century: Consequences of Massive Unsterile Injecting for the

Emergence of Human Pathogens " at the Royal Society in London at a meeting

entitled " Origins of HIV and the AIDS Epidemic. "

In the paper, these world-renowned scientists substantiate

UNIVEC's long held claim that " continued massive unsterile injecting has the

capacity to significantly alter the global ecology of infectious diseases,

accelerating epidemic spread of human pathogens. " According to Dr. Marx,

Tulane University's Director of AIDS Research and Chief of Virology, and Dr.

Drucker, Director of the Division of Community Health at New York City's

Montefiore Medical Center, the introduction of antibiotics in the 1950's led

to an abrupt and massive increase in unsterile injections and transmission

of several newly emerged human pathogens, significantly HIV and Hepatitis B

and C. The doctors warn that new strains of HIV or other pathogens could

emerge as a result of current practices.

" In addition to facilitating the spread of existing diseases, "

say Drs. Marx and Drucker, " massive unsterile injecting may also have

fostered the creation of new ones. "

" We hypothesize that the massive increase in unsterile injecting

in Africa associated with the introduction of antibiotics in the 1950's was

the modern `event' that allowed several weakly pathogenic simian virus, long

native to Sub Saharan Africa, to increase in pathogenicity and complete

their genetic adaptation to human hosts, emerging as the first epidemic

strain of HIV by 1959. "

Schoenfeld, Chairman of UNIVEC, said, " these respected

experts confirm our call for the exclusive use of auto-disable syringes in

mass immunization programs and for clinical use. As the World Health

Organization estimates, unsafe injections cause approximately 30,000 new HIV

infections, 8 million HBV infections and 1.2 million HCV infections

world-wide every year. "

" Why does the world's medical community continue to ignore these

figures?, " said Schoenfeld. " What it should do is stop the practice of

allowing multi-use syringes in every immunization and clinical program the

world over. Only when we adopt an auto-disable syringe policy, to be

mandatory in all mass vaccination programs, will we contribute significantly

to the scourge of disease around the world. "

The UNIVEC technology is for auto-disable syringes that can

effectively deliver vaccines in a safer manner than with traditional

syringes. The UNIVEC syringe prevents re-use and the needless spread of

disease. The devices can deliver predetermined doses from 0.05 to 1cc needed

to deliver medication, including vaccines, which may prevent contagious

diseases from spreading.

UNIVEC is a world leader in auto-disable syringes and is leading

the global movement for a conversion to auto-disable syringes from

traditional multi-use syringes. Traditional multi-use disposable syringes

are acknowledged by the World Health Organization to be responsible for the

spread of disease to millions of people each year.

Statements herein that are not descriptions of historical facts

are forward-looking and subject to risk and uncertainties. Actual results

could differ materially from those currently anticipated due to a number of

factors, including those set forth in the company's Securities and Exchange

filings under " Risk Factors, " including risks relating to dependence on

third parties; future capital needs; and risks relating to the

commercialization, if any, of the company's proposed products (such as

marketing, safety, regulatory, patent product liability, supply, competition

and other risks.)

Contact: UNIVEC Corporation

Schoenfeld, 631/777-2000

UNIVEC@...